Relapsed Diffuse Large B-Cell Lymphoma Treated by Reduced-Intensity Allogeneic Stem Cell Transplantation with Donor Lymphocyte Infusion

被引:0
作者
Chaudhry, Qamar-un-Nisa [1 ]
Ahmed, Parvez [1 ]
Ullah, Khalil [1 ]
Satti, Tariq Mehmood [1 ]
Raza, Shahid
Mehmood, Syed Kamran
Akram, Mohammed
Ahmed, Suhaib [2 ]
机构
[1] Armed Forces Bone Marrow Transplant Ctr, Dept Haematol, Near CMH, Rawalpindi, Pakistan
[2] Armed Forces Inst Pathol, Dept Haematol, Rawalpindi, Pakistan
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2010年 / 20卷 / 03期
关键词
Relapsed non-Hodgkin's lymphoma; Reduced-intensity conditioning transplantation; Donor lymphocyte infusion; Diffuse B-cell lymphoma; NON-HODGKINS-LYMPHOMAS; ALEMTUZUMAB; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 42 years old male with relapsed diffuse large B-cell lymphoma was given second-line chemotherapy followed by reduced intensity allogeneic stem cell transplantation from HLA matched brother. Twelve weeks posttransplant, his disease relapsed evidenced by the appearance of lymphoma cells in the peripheral blood and declining donor chimerism. Donor lymphocyte infusion was given that induced complete lymphoma remission. The patient is well 3 years posttransplant with his disease in complete remission.
引用
收藏
页码:211 / 213
页数:3
相关论文
共 50 条
  • [31] Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
    Tomohiko Kamimura
    Toshihiro Miyamoto
    Noriaki Kawano
    Akihiko Numata
    Yoshikiyo Ito
    Yong Chong
    Koji Nagafuji
    Takanori Teshima
    Shin Hayashi
    Koichi Akashi
    International Journal of Hematology, 2012, 95 : 725 - 730
  • [32] Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Chancoco, Christina
    Alousi, Amin M.
    Shpall, Elizabeth J.
    Popat, Uday R.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Ciurea, Stefan
    Younes, Anas
    Fanale, Michelle A.
    Acholonu, Sandra
    Valverde, Rosamar
    Champlin, Richard E.
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 499 - 502
  • [33] Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
    Ghobadi, Armin
    Choi, Jaebok
    Fiala, Mark A.
    Fletcher, Theresa
    Liu, Jingxia
    Eissenberg, Linda G.
    Abboud, Camille
    Cashen, Amanda
    Vij, Ravi
    Schroeder, Mark A.
    Pusic, Iskra
    Stockerl-Goldstein, Keith
    Jacoby, Meagan
    Uy, Geoffrey
    DiPersio, John
    Westervelt, Peter
    LEUKEMIA RESEARCH, 2016, 49 : 1 - 6
  • [34] Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita
    Nishio, Nobuhiro
    Takahashi, Yoshiyuki
    Ohashi, Haruhiko
    Doisaki, Sayoko
    Muramatsu, Hideki
    Hama, Asahito
    Shimada, Akira
    Yagasaki, Hiroshi
    Kojima, Seiji
    PEDIATRIC TRANSPLANTATION, 2011, 15 (02) : 161 - 166
  • [35] Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases
    Umeda, Katsutsugu
    Adachi, Souichi
    Tanaka, Shiro
    Miki, Mizuka
    Okada, Keiko
    Hashii, Yoshiko
    Inoue, Masami
    Cho, Yuko
    Koh, Katsuyoshi
    Goto, Hiroaki
    Kajiwara, Ryosuke
    Hyakuna, Nobuyuki
    Kato, Koji
    Morio, Tomohiro
    Yabe, Hiromasa
    PEDIATRIC BLOOD & CANCER, 2016, 63 (12) : 2221 - 2229
  • [36] Allogeneic Hematopoietic Stem Cell Transplant for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell Therapy
    Hilal, Talal
    Mountjoy, Luke J.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (06) : 599 - 607
  • [37] Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study
    Kim, Ji-Won
    Kim, Sung-Won
    Tada, Kohei
    Fukuda, Takahiro
    Lee, Je-Hwan
    Lee, Je-Jung
    Kwon, Ji-Hyun
    Bang, Soo-Mee
    Kim, Inho
    Yoon, Sung-Soo
    Lee, Jong Seok
    Park, Seonyang
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1345 - 1351
  • [38] Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: Case report and literature review
    Komrokji, R
    Ifthikharuddin, JJ
    Felgar, RE
    Abboud, CN
    Wedow, LA
    Connaughton, A
    Bennett, JM
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 76 (04) : 389 - 394
  • [39] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [40] Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation
    Slesarchuk, O. A.
    Babenko, E. V.
    Semenova, E. V.
    Bondarenko, S. N.
    Estrina, M. A.
    Morozova, E. V.
    Paina, O. V.
    Vavilov, V. N.
    Smirnov, B. I.
    Zubarovskaya, L. S.
    Afanasyev, B. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (07) : 26 - 33